Systemic exposure of SARS-CoV-2-infected rhesus macaques to nelfinavir
A group of 3 rhesus macaques received nelfinavir (suspended in 0.5%CMC-Na) at 200 mg/kg via nasogastric administration route. After inoculation, the nelfinavir treatment was continued twice daily. The plasma concentrations of nelfinavir at 5 h after dosing (C